BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23873735)

  • 1. Propagation of biochirality: crossovers and nonclassical crystallization kinetics of aspartic acid in water.
    Lee T; Lin YK; Tsai YC; Lee HL
    Chirality; 2013 Nov; 25(11):768-79. PubMed ID: 23873735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential Amplification of Amino Acid Enantiomeric Excess by Conglomerate and Racemic Compound: Plausible Prebiotic Route Towards Homochirality.
    Sharma A
    Orig Life Evol Biosph; 2023 Dec; 53(3-4):175-185. PubMed ID: 37831272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
    Huang J; Chen S; Guzei IA; Yu L
    J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
    Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
    Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleation kinetics, growth and studies of β-alanine single crystals.
    Shanthi D; Selvarajan P; HemaDurga KK; Lincy Mary Ponmani S
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Jun; 110():1-6. PubMed ID: 23548638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.
    Fayzullin RR; Lorenz H; Bredikhina ZA; Bredikhin AA; Seidel-Morgenstern A
    J Pharm Sci; 2014 Oct; 103(10):3176-82. PubMed ID: 25091705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
    Wang X; Wang XJ; Ching CB
    Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enabling Direct Preferential Crystallization in a Stable Racemic Compound System.
    Harfouche LC; Brandel C; Cartigny Y; Ter Horst JH; Coquerel G; Petit S
    Mol Pharm; 2019 Nov; 16(11):4670-4676. PubMed ID: 31545612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of preferential crystallization to resolve racemic compounds in a hybrid process.
    Lorenz H; Polenske D; Seidel-Morgenstern A
    Chirality; 2006 Nov; 18(10):828-40. PubMed ID: 16917833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the Crystal Structures of Enantiopure and Racemic Mandelic Acids Determined by Kinetics or Thermodynamics?
    Hylton RK; Tizzard GJ; Threlfall TL; Ellis AL; Coles SJ; Seaton CC; Schulze E; Lorenz H; Seidel-Morgenstern A; Stein M; Price SL
    J Am Chem Soc; 2015 Sep; 137(34):11095-104. PubMed ID: 26244445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies.
    Li ZJ; Zell MT; Munson EJ; Grant DJ
    J Pharm Sci; 1999 Mar; 88(3):337-46. PubMed ID: 10052993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of different techniques of preferential crystallization for enantioseparation of racemic compound forming systems.
    Polenske D; Lorenz H; Seidel-Morgenstern A
    Chirality; 2009 Aug; 21(8):728-37. PubMed ID: 18989897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomeric crystallization from DL-aspartic and DL-glutamic acids: implications for biomolecular chirality in the origin of life.
    Viedma C
    Orig Life Evol Biosph; 2001 Dec; 31(6):501-9. PubMed ID: 11770258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides.
    Wang L; Qiu SR; Zachowicz W; Guan X; Deyoreo JJ; Nancollas GH; Hoyer JR
    Langmuir; 2006 Aug; 22(17):7279-85. PubMed ID: 16893227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral symmetry breaking and complete chiral purity by thermodynamic-kinetic feedback near equilibrium: implications for the origin of biochirality.
    Viedma C
    Astrobiology; 2007 Apr; 7(2):312-9. PubMed ID: 17480162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation of a metastable conglomerate using a combined computational and controlled crystallization approach.
    Davey RJ; Sadiq G; Back K; Wilkinson L; Seaton CC
    Chem Commun (Camb); 2012 Feb; 48(14):1976-8. PubMed ID: 22117223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three different types of chirality-driven crystallization within the series of uniformly substituted phenyl glycerol ethers.
    Bredikhin AA; Bredikhina ZA; Novikova VG; Pashagin AV; Zakharychev DV; Gubaidullin AT
    Chirality; 2008 Nov; 20(10):1092-103. PubMed ID: 18767134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific morphogenesis of aspartic acid helical crystals through molecular recognition.
    Oaki Y; Imai H
    Langmuir; 2007 May; 23(10):5466-70. PubMed ID: 17432886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origins of hydration differences in homochiral and racemic crystals of aspartic acid.
    Juliano TR; Korter TM
    J Phys Chem A; 2015 Feb; 119(8):1396-403. PubMed ID: 25635903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral symmetry breaking via crystallization of the glycine and α-amino acid system: a mathematical model.
    Blanco C; Hochberg D
    Phys Chem Chem Phys; 2011 Jul; 13(28):12920-34. PubMed ID: 21695347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.